NIR‐I/II‐Responsive Niosomes Co‐Encapsulating Plasmonic Gold Nanorods and IR1061 for Phototherapeutic Ablation of Cancer Cells

View at publisher Summarise with VIRAT
Authors: Rishabh Kumar Srivastava, Shubham Kumar Singh, Antony Vincy, Chiranjeevi Korupalli, Raviraj Vankayala
Cited by: 0
References: 17

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Near-infrared (NIR) light-responsive nanomaterials have emerged as powerful tools for cancer therapy, yet stable and biocompatible delivery of NIR-II agents remains a major challenge. In this work, we develop NIR-I/II-responsive niosomes co-encapsulating plasmonic gold nanorods (GNRs) and the NIR-II dye, IR1061, forming a multifunctional nanoplatform for effective phototherapeutic ablation of cancer cells. The niosomal system provides robust encapsulation, improved dispersion stability, and biocompatibility for both photoactive components. Upon NIR-I/II laser irradiation, the nanoplatform exhibits strong photothermal heating and substantial reactive oxygen species generation due to the synergistic integration of plasmonic GNRs and dye-mediated effects. In vitro evaluations demonstrate efficient cellular uptake, potent photoinduced cytotoxicity, and minimal dark toxicity. The integration of photothermal and photodynamic mechanisms results in markedly enhanced therapeutic efficacy compared with individual agents. This study highlights the potential of niosomes as versatile and efficient nanocarriers for dual NIR-window phototherapy, offering a promising route for precise and minimally invasive cancer treatment.

Fields of Study & Subjects

Nanoplatforms for cancer theranostics Photodynamic Therapy Research Studies Gold and Silver Nanoparticles Synthesis and Applications

Publication details

Journal / source
ChemBioChem
Volume
27
Issue
7
Pages
e202500977–e202500977
Publication date
30 March 2026
Language
EN